What is NDC 70771-1110?

70771-1110 is the product NDC for mesalamine, Mesalamine 800 mg/1 tablet, delayed release, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for mesalamine?

58 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

mesalamine NDC 70771-1110 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1110Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1110Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1110-4	7077111100470771111004	10 BLISTER PACK in 1 CARTON (70771-1110-4) / 10 TABLET, DELAYED RELEASE in 1 BLISTER PACK (70771-1110-2)Marketed from Aug 2, 2018
70771-1110-8	7077111100870771111008	180 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1110-8)Marketed from Aug 2, 2018

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): mesalamine
Generic name (nonproprietary): mesalamine
Active ingredients: Mesalamine — 800 mg/1
Dosage form: Tablet, Delayed release
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203286
Marketing start: Aug 2, 2018
Listing expires: Dec 31, 2027
Other FDA classes: Aminosalicylic Acids (Chemical structure)
Identifiers: Product ID 70771-1110_b22ba9c9-d644-4ea2-a21d-0f8dee960c43SPL ID b22ba9c9-d644-4ea2-a21d-0f8dee960c43SPL set ID 52d96501-47f3-45d8-a181-98763b9f8965RxCUI 833234UNII 4Q81I59GXCUPC 0368382435286
Pharmacologic class: Aminosalicylate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771111004 followed by a unit qualifier and the quantity

Package 70771-1110-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 30, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1110

What is NDC 70771-1110?: 70771-1110 is the product NDC for mesalamine, Mesalamine 800 mg/1 tablet, delayed release, listed with the FDA by Zydus Lifesciences Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: mesalamine.
What is the active ingredient?: Mesalamine.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for mesalamine?: 58 other product NDCs are listed under this name. See all mesalamine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other mesalamine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Mesalamine	Mesalamine 4 g/60mL	SuspensionRectal	KLM Laboratories Private Limited	84725-002	84725-0002-0484725-0002-10
Mesalamine	Mesalamine 250 mg/1	Capsule, Extended releaseOral	Sandoz Inc	0781-2791	00781-2791-64
Mesalamine	Mesalamine 500 mg/1	Capsule, Extended releaseOral	Sandoz Inc	0781-2793	00781-2793-72
Mesalamine	Mesalamine 1.2 g/1	Tablet, Delayed releaseOral	Nuvaila Limited	84612-175	84612-0175-13
Mesalamine	Mesalamine 4 g/60mL	SuspensionRectal	ANI Pharmaceuticals, Inc.	70954-301	70954-0301-20
Mesalamine	Mesalamine 375 mg/1	Capsule, Extended releaseOral	Camber Pharmaceuticals, Inc.	31722-489	31722-0489-12
Mesalamine	Mesalamine 1000 mg/1	SuppositoryRectal	Rising Pharma Holdings, Inc.	16571-246	16571-0246-0316571-0246-72
Mesalamine	Mesalamine 800 mg/1	Tablet, Delayed releaseOral	Amneal Pharmaceuticals LLC	65162-360	65162-0360-18
Mesalamine	Mesalamine 1.2 g/1	Tablet, Delayed releaseOral	NorthStar RxLLC	72603-304	72603-0304-01
Mesalamine	Mesalamine 800 mg/1	Tablet, Delayed releaseOral	AvKARE	42291-489	42291-0489-18

All 59 mesalamine NDCs

Other NDCs under ANDA 203286

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203286
Product	Strength	Form · route	Labeler	Product NDC
Mesalamine	Mesalamine 800 mg/1	Tablet, Delayed releaseOral	American Health Packaging	60687-408
mesalamine	Mesalamine 800 mg/1	Tablet, Delayed releaseOral	Zydus Pharmaceuticals USA Inc.	68382-435